Abstract
The retinoic acid receptor alpha (RARA) gene is disrupted by PML/RARA fusion in acute promyelocytic leukemia (APL). The P2 promoter of RARA, controlling the RARα2 isoform, contains an RA-responsive element and may be targeted in APL. To test whether aberrant methylation of P2 was involved, 47 APL at diagnosis, 16 APL at first relapse, 50 acute myeloid leukemia (AML) and 22 acute lymphoblastic leukemia (ALL) were tested by methylation-specific polymerase chain reaction. RARA P2 methylation was highly associated with APL (APL: 25/63 vs AML/ALL: 2/75, P<0.0001). P2 methylation occurred at similar frequencies in APL at diagnosis and relapse, suggesting it was an initiating leukemogenic event. In the APL line NB4, RARα2 was not expressed, with the untranslocated RARA shown to be P2 methylated. 5-Azacytadine treatment of NB4 led to progressive P2 demethylation and re-expression of RARα2, confirming that RARA methylation collaborated with PML/RARA in totally suppressing RARα. In APL, RARA P2 methylation was unrelated to gender, age, presenting leukocyte counts and additional cytogenetic aberrations. For APL patients receiving all-trans retinoic acid for induction, P2 methylation did not affect the complete remission rates and survivals. RARA is the first myeloid-specific transcription factor shown to be dysregulated by both translocation and aberrant methylation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
De The H, Chomienne C, Lanotte M, Degos L, Dijean A . The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 347; 558: 1990.
Tenen DG, Hromas R, Licht JD, Zhang DE . Transcription factors, normal myeloid development, and leukemia. Blood 1997; 90: 489–519.
Chomienne C, Balitrand N, Ballerini P, Castaigne S, de The H, Degos L . All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. J Clin Invest 1991; 88: 2150–2154.
Melnick A, Licht JD . Blood, 1999 Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167–3215.
Chih DY, Chumakov AM, Park DJ, Silla AG, Koeffler HP . Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon). Blood 1997; 90: 2987–2994.
Zelent A, Guidez F, Melnick A, Waxmaan S, Licht JD . Translocations of the RARα gene in acute promyelocytic leukaemia. Oncogene 2001; 20: 7186–7203.
Zhu J, Heyworth CM, Glasow A, Huang QH, Petrie K, Lanotte M et al. Lineage restriction of the RARalpha gene expression in myeloid differentiation. Blood 2000; 98: 2563–2567.
Collins SJ . The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 2002; 16: 1896–1905.
Lian Z, Kluger Y, Greenbaum DS, Tuck D, Gerstein M, Berliner N et al. Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell line. Blood 2002; 100: 3209–3220.
Leroy P, Krust A, Zelent A, Mendelsohn C, Garnier JM, Kastner P et al. Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. EMBO J 1991; 10: 59–69.
Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP . Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141–196.
Robertson KD, Wolffe AP . DNA methylation in health and disease. Nat Rev 2000; 1: 11–19.
Singal R, Ginder GD . DNA methylation. Blood 1999; 93: 4059–4070.
Chim CS, Liang R, Kwong YL . Gene promoter hypermethylation in hematologic malignancies. Hematol Oncol 2002; 20: 167–176.
Jones PA, Laird PW . Cancer epigenetics comes of age. Nat Genet 1999; 21: 163–167.
Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H . DNA methylation represses transcription in vivo. Nat Genet 1999; 22: 203–206.
Chim CS, Liang R, Tam C, Kwong YL . P15 and P16 promoter methylation in acute promyelocytic leukemia. J Clin Oncol 2001; 19: 2033–2040.
Chim CS, Tam C, Liang R, Kwong YL . P15 and P16 gene methylation in adult acute leukemia: lack of prognostic significance. Cancer 2001; 91: 2222–2229.
Chim CS, Wong AS, Kwong YL . Infrequent hypermethylation of CEBPA promoter in acute myeloid leukaemia. Br J Haematol 2002; 119: 988–990.
Chim CS, Wong ASY, Kwong YL . Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance. Br J Haematol 2003; 122: 571–578.
Chim CS, Wong ASY, Kwong YL . Absence of p300 methylation in acute leukemias. Cancer Genet Cytogenet 2004; 150: 164–167.
Chim CS, Wong ASY, Kwong YL . Epigenetic inactivation of the INK4/cyclin D/cyclin-dependent kinase cell cycle control pathway in acute leukemias. Ann Haematol 2003; 82: 738–742.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French–American–British (FAB) co-operative group. Br J Haematol 1976; 33: 451–458.
Second MIC Cooperative Study Group. Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Br J Haematol 1988; 68: 487–494.
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821–9826.
Chim CS, Fung TK, Cheung J, Liang R Kwong YL . SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway. Blood 2004; 103: 4630–4635.
Pang A, Au WY, Kwong YL . Caveolin-1 gene is coordinately regulated with the multidrug resistance 1 gene in normal and leukemic bone marrow. Leukemia Res 2004; 28: 973–977.
Pandolfi PP . In vivo analysis of the molecular genetics of acute promyelocytic leukemia. Oncogene 2001; 20: 5726–5735.
Morosetti R, Grignani F, Liberatore C, Pelicci PG, Schiller GJ, Kizaki M et al. Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. Blood 1996; 87: 4399–4403.
Parrado A, West R, Jordan D, Bastard C, McKenna S, Whittaker JA et al. Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignancies. Br J Haematol 1999; 104: 738–741.
Yoshida H, Naoe T, Fukutani H, Kiyoi H, Kubo K, Ohno R . Analysis of the joining sequences of the t(15;17) translocation in human acute promyelocytic leukemia: sequence non-specific recombination between the PML and RARA genes within identical short stretches. Genes Chromosomes Cancer 1995; 12: 37–44.
Knudson AG . Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001; 1: 157–162.
Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira-Y-Lopez R . Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 2002; 13: 335–341.
Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 1998; 391: 815–818.
Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 2002; 295: 1079–1082.
Labrecque J, Allan D, Chambon P, Iscove NN, Lohnes D, Hoang T . Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma. Blood 1998; 92: 607–615.
Esteller M, Fraga MF, Paz MF, Campo E, Colomer D, Novo FJ et al. Cancer epigenetics and methylation. Science 2002; 297: 1807–1808.
He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V et al. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci USA 1997; 94: 2551–2556.
Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG et al. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997; 94: 2551–2556.
Acknowledgements
We thank Professor LC Chan, Drs Edmond Ma and Clarence Lam for helping with the diagnosis, and the University Research Fund and Kadoorie Charitable Foundation for funding support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chim, CS., Wong, SY., Pang, A. et al. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Leukemia 19, 2241–2246 (2005). https://doi.org/10.1038/sj.leu.2403937
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403937
Keywords
This article is cited by
-
Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1
Oncology and Therapy (2019)
-
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies
Diagnostic Pathology (2018)
-
Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region
Blood Cancer Journal (2014)
-
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Journal of Translational Medicine (2011)
-
Using cell fate attractors to uncover transcriptional regulation of HL60 neutrophil differentiation
BMC Systems Biology (2009)